Artemis Medicare Services approves FY26 results, recommends Re. 0.45 dividend, appoints directors
Artemis Medicare Services reported audited financial results for the quarter and year ended March 31, 2026. The company recommended a final dividend of Re. 0.45 per share. Mr. Tapan Mitra was appointed as an Independent Director, effective May 8, 2026. Shareholder approval will be sought for Dr. Girdhar J. Gyani's appointment and the re-appointment of auditors.
The financial results and dividend recommendation have a direct impact on shareholders. The appointment of directors and re-appointment of auditors are important governance events that can influence investor confidence.
The company reported positive financial results, recommended a dividend, and made strategic appointments, all of which are generally viewed favorably by investors.
Artemis Medicare Services Limited announced the outcome of its Board Meeting held on May 8, 2026. The Board approved the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2026.
The company recommended a Final Dividend of Re. 0.45 per Equity Share (45%) for the financial year ended March 31, 2026, subject to shareholder approval at the upcoming Annual General Meeting (AGM). This dividend will be paid within 30 days of the AGM conclusion.
Key appointments were made: Mr. Tapan Mitra was appointed as an Additional Director in the capacity of Independent Director for a period of 3 years, effective from May 8, 2026. Additionally, the Board approved seeking shareholder approval at the AGM for the re-appointment of Dr. Girdhar J. Gyani as an Independent Director for a 3-year term, effective August 1, 2026. The shareholders' approval will also be sought for the re-appointment of M/s. T R Chadha & Co LLP as Statutory Auditors for a second term of 5 years, from the conclusion of the 22nd AGM until the 27th AGM in 2031.
The Board also approved seeking shareholder approval to extend the period for utilization of unutilized funds from a preferential issue by 18 months. The financial results, along with the Auditors' Report, were published in newspapers and will be available on the websites of NSE, BSE, and the company. The Board meeting commenced at 4:00 PM and concluded at 5:50 PM.
What to do with a filing like this
Artemis Medicare Services Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Artemis Medicare Services Limited. Read the original for the full detail.